“…Multiple studies have demonstrated the critical role of CD8 + T-cells in controlling HIV-1 replication [ [28] , [29] , [30] ], attributing the control of viremia and slower progression of HIV-1 infection to CD8 + T-cell responses targeting peptides derived from HIV-1 Gag. Previously, we determined the CD8 + T-cell response to Gag peptides restricted to the HLA-A*02 allele and could associate the peptide binding affinity with CD8 + T-cells polyfunctionality [ 22 ]. Importantly, HLA-I allotype restriction is a limitation for developing effective peptide-based vaccines; therefore, identifying immunodominant Gag peptides restricted to the most prevalent HLA-I molecules makes peptide-based vaccines accessible to larger patient cohorts [ 31 , 32 ].…”